 7. Receipt of a prior investigational study agent within 4 weeks prior to screening visit if required by local regulation. Note- patients who have received anti-CD19 CART cells e.g. CART19CTL019 on an investigational study where cell infusion occurred greater than 4 weeks before the screening visit are NOT excluded. 